expert resume writing how to find a dissertation free research paper download management summary business plan how to write my term paper homework help the romans phd thesis on economics write an essay for me uk
SHARE
05 February 2016

A New Tool for Treating Insulin Resistance


The innovative treatment could help people suffering from type-2 diabetes.

For the past several years, INAF’s scientific director, Dr. André Marette (Faculty of Medicine), and his team have been exploring glycemic problems that are at the root of a number of metabolic disorders. He recently took his research to a new level through the publication of a new U.S. patent in collaboration with doctoral student Phillip White. The innovation aims to regulate blood sugar  using a molecule derived from an Omega-3 fatty acid.
The molecule, called protectin DX (PDX), stimulates the production and release of interleukin-6 (IL-6) by muscle cells. The chemical works in two ways: it facilitates the capturing of blood glucose by muscles and it activates a protein that reduces glucose production by the liver.


“What is interesting about PDX is that it acts directly on muscles,” explains Dr. Marette. “It actually reproduces what happens when a person exercises. I should note that it is not a substitute for physical activity because exercise has cardiovascular and hormonal benefits that surpass the metabolic effects on muscles.”

Read the full article [in French only]